Novartis AG (Novartis AG) Current Accrued Expense : $0 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Current Accrued Expense?

Novartis AG's Current Accrued Expense for the quarter that ended in Mar. 2024 was $0 Mil.

Novartis AG's quarterly Current Accrued Expense increased from Sep. 2023 ($0 Mil) to Dec. 2023 ($2,308 Mil) but then declined from Dec. 2023 ($2,308 Mil) to Mar. 2024 ($0 Mil).

Novartis AG's annual Current Accrued Expense declined from Dec. 2021 ($2,221 Mil) to Dec. 2022 ($2,177 Mil) but then increased from Dec. 2022 ($2,177 Mil) to Dec. 2023 ($2,308 Mil).

Novartis AG Current Accrued Expense Historical Data

The historical data trend for Novartis AG's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Current Accrued Expense Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

2,123.00

2,301.00

2,221.00

2,177.00

2,308.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	2,308.00	-

Novartis AG Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Novartis AG Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Novartis AG's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.